News

PreDiaWell® Achieves ORCHA Certification with an Outstanding 95% Score We are delighted to announce that PreDiaWell® has successfully passed ORCHA […]

Tesu Health to Present Clinical Trial Results at ATTD 2025 Tesu Health is pleased to announce its participation in the

Positive Topline Results from the TH001_1001 Clinical Trial Evaluating PreDiaWell® in Adults with Prediabetes We are pleased to announce positive

Tesu Health at Diabetes Professional Care 2024 On 15-16 October 2024, Tesu Health proudly attended Diabetes Professional Care (DPC) at

Patient Enrolment Completed in TH001_1001 Tesu Health is pleased to announce the completion of patient enrolment in the clinical trial

Tesu Health at Cambridge Tech Week 2024 From 9 to 13 September 2024, Cambridge Tech Week brought together some of

Announcing our seed funding round! TESU HEALTH RAISES SEED INVESTMENT AT A $2.5M VALUATION TO FURTHER ITS MISSION OF TRANSFORMING

Tesu Health Joins Cambridge Life Sciences Market Access Programme Tesu Health has been chosen as one of the ten companies

Two New R&D Projects in Chronic Diseases Tesu Health, today announced that two of its research and development projects have

The Founder Institute Spring 2023 FI Core Program Tesu Health has recently been accepted into The Founder Institute‘s Istanbul –